Texolite Joint Compound
Product Description
Texolite Joint Compound was a finishing and taping compound manufactured by United States Gypsum (USG), one of the dominant suppliers of drywall and gypsum-based construction materials throughout the twentieth century. Produced from approximately 1952 through 1976, Texolite was formulated to fill, smooth, and finish seams between drywall panels, cover nail heads, and prepare interior wall surfaces for painting or texturing.
During the post-World War II construction boom, joint compounds like Texolite became essential materials in residential, commercial, and industrial building projects across the United States. The product was sold in powder form — intended to be mixed with water on the job site — as well as in pre-mixed formulations. Its widespread availability and the reputation of its manufacturer made Texolite a common fixture on construction sites throughout the 1950s, 1960s, and into the mid-1970s.
United States Gypsum, headquartered in Chicago, Illinois, had a long history of producing gypsum-based building materials and operated manufacturing facilities at multiple locations nationwide. The company marketed Texolite under its broader portfolio of professional finishing products, positioning the compound as a reliable material for contractors and tradespeople working on both new construction and renovation projects.
Production of Texolite in its asbestos-containing formulation continued until 1976, when regulatory pressure and growing awareness of asbestos health hazards led manufacturers across the industry to reformulate or discontinue asbestos-containing joint compounds.
Asbestos Content
Texolite Joint Compound contained chrysotile asbestos, the most commercially prevalent form of asbestos used in building products during the twentieth century. Chrysotile, sometimes called “white asbestos,” is a serpentine mineral fiber that was valued by manufacturers for its flexibility, binding strength, and resistance to cracking and shrinkage — properties that made it particularly useful in joint compound formulations.
In joint compounds, chrysotile fibers served as a reinforcing agent, helping the dried compound resist the cracking and flaking that could otherwise occur as interior walls expanded and contracted with temperature and humidity changes. The fibers also contributed to the workability of the wet compound, making it easier to apply and feather at the edges.
Litigation records document that Texolite Joint Compound contained asbestos as a functional ingredient in its formulation during the years of production identified above. The concentration of asbestos in joint compound products of this era varied by formulation, but plaintiffs alleged that the levels present in Texolite were sufficient to release respirable fibers into the air during normal product use.
Chrysotile fibers, once inhaled, can penetrate deep into lung tissue. Medical and regulatory literature, including findings underlying OSHA’s asbestos standards and the Environmental Protection Agency’s AHERA regulations, documents the association between chrysotile inhalation and serious diseases including mesothelioma, asbestosis, and lung cancer.
How Workers Were Exposed
Exposure to asbestos fibers from Texolite Joint Compound occurred principally during the mixing, application, sanding, and cleanup stages of drywall finishing work. The nature of these tasks meant that workers could be exposed repeatedly and over extended periods throughout their careers.
Mixing: When Texolite was supplied in dry powder form, workers mixed the compound by hand or with mechanical mixers. This process generated visible dust clouds that contained both the compound’s mineral components and, litigation records document, respirable asbestos fibers. Workers performing this task in enclosed or poorly ventilated spaces faced particularly concentrated exposures.
Application and Finishing: Applying joint compound with taping knives and broad blades was a skilled trade task that involved direct contact with the product and proximity to freshly applied material as it dried. As the compound was worked across wall seams and feathered at the edges, fibers could be disturbed and become airborne.
Sanding: Dry sanding of cured joint compound was among the most hazardous tasks associated with these products. Plaintiffs alleged that sanding Texolite and similar asbestos-containing compounds generated substantial quantities of fine, airborne dust that was highly respirable. Workers performing hand sanding or using mechanical sanders in enclosed rooms without adequate respiratory protection faced prolonged, direct inhalation exposure. Bystander workers — those working in the same areas without directly handling the compound — were also exposed through airborne dust that migrated throughout a job site.
Cleanup: Sweeping dried compound debris and disposing of empty bags or containers also disturbed settled dust, creating secondary exposure opportunities for workers and others present on the job site.
Industrial workers generally, including those employed in facilities undergoing renovation or construction during this era, may have encountered Texolite as part of building and maintenance projects. Workers in environments such as manufacturing plants, warehouses, and other industrial settings often had drywall finishing performed during operations, meaning that non-construction employees could also be present during tasks that generated asbestos-containing dust.
The cumulative and repeated nature of these exposures — particularly across a career spanning the full period of Texolite’s production — is central to the claims brought by individuals diagnosed with asbestos-related diseases.
Documented Trust Fund / Legal Options
Trust Fund Status: United States Gypsum has not established an asbestos bankruptcy trust fund. The company did not undergo asbestos-related bankruptcy proceedings of the type that resulted in the creation of Section 524(g) trusts for other major asbestos product manufacturers. As a result, there is no USG-affiliated trust through which claims related to Texolite Joint Compound may be submitted.
Litigation History: Texolite Joint Compound has been the subject of asbestos personal injury litigation. Litigation records document claims brought against United States Gypsum by plaintiffs who alleged exposure to Texolite and subsequent diagnosis with asbestos-related diseases including mesothelioma, lung cancer, and asbestosis. Plaintiffs alleged that USG knew or should have known of the health hazards associated with asbestos-containing joint compounds and failed to provide adequate warnings to workers who used or were exposed to these products.
Legal Pathways: Individuals diagnosed with mesothelioma, asbestosis, lung cancer, or other asbestos-related conditions who have a documented history of exposure to Texolite Joint Compound may have the following legal options available:
- Direct civil litigation against United States Gypsum and potentially other parties in the chain of distribution, supply, or use of asbestos-containing joint compounds
- Multi-defendant asbestos litigation, in which claims involving multiple products and manufacturers are consolidated or coordinated in state or federal court
- Workers’ compensation claims, depending on the jurisdiction and circumstances of employment
- Claims against other asbestos trusts, if the individual was also exposed to asbestos-containing products from manufacturers who did establish bankruptcy trusts
Next Steps: Because Texolite claims must be pursued through active litigation rather than a trust fund submission process, the legal pathway is more complex and time-sensitive. Statutes of limitations for asbestos claims vary by state and typically begin running from the date of diagnosis rather than the date of exposure. Individuals with potential Texolite exposure should consult an attorney experienced in asbestos litigation to evaluate their claim, preserve evidence of exposure, and meet applicable filing deadlines.
This article is provided for informational purposes only and does not constitute legal advice. Individuals seeking legal guidance regarding asbestos exposure or related disease should consult a qualified asbestos litigation attorney.